Detalhe da pesquisa
1.
Discovery of Sovleplenib, a Selective Inhibitor of Syk in Clinical Development for Autoimmune Diseases and Cancers.
ACS Med Chem Lett
; 15(5): 595-601, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746892
2.
Development and validation of a sensitive liquid chromatography-tandem mass spectrometry method for the determination of paeoniflorin in rat brain and its application to pharmacokinetic study.
J Chromatogr B Analyt Technol Biomed Life Sci
; 857(1): 32-9, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17631428
3.
A semi-physiologically-based pharmacokinetic model characterizing mechanism-based auto-inhibition to predict stereoselective pharmacokinetics of verapamil and its metabolite norverapamil in human.
Eur J Pharm Sci
; 50(3-4): 290-302, 2013 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23916407